Delivery Order SPE2DB20D3103-SPE2DB22FP5K0
- Not listed
- This federal contract award is for the delivery of POSACONAZOLE DR 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,681.28 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 3, 2025 and was awarded on February 28, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $7,993.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of POSACONAZOLE DR 100 MG TABLET UD 20S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 29, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a...
- This federal contract award, valued at $3,827.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to deliver POSACONAZOLE DR 100 MG TABLET 60S. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,105.13, for the supply of POSACONAZOLE DR 100 MG TABLET 60S. The place of performance is Conshohocken, PA. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $5,365.46, is for the delivery of 4564491405 POSACONAZOLE DR 100 MG TABLET 60S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of May 6, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,410.94 firm fixed-price delivery order is for the supply of POSACONAZOLE DR 100 MG TABLET 60S, a pharmaceutical product, with a performance period through March 2025. The contract award is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $1,254.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 tablets of POSACONAZOLE DR 100 MG, a prescription medication, with a performance period extending until April 29, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,469.43, is for the supply of POSACONAZOLE DR 100 MG TABLET 60S, a medication used for the treatment of certain fungal infections. The contract is a firm fixed-price delivery order with a final completion date of July 5, 2024. The contract does not have a set-aside designation, indicating it...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor AmerisourceBergen Drug Corp, Corporate Office Division. The contract, valued at $1,753.63, is a Delivery Order for the supply of 4,566,088,032 units of the pharmaceutical product POSACONAZOLE DR 100 MG TABLET 60S. The contract has an ultimate completion date of October 15, 2024 and a firm fixed price pricing type. This contract award is part of a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a delivery order with a ceiling value of $8,300.68 for the supply of POSACONAZOLE DR 100 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp holds...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FP5K0Delivery Order
This federal contract award is for the delivery of 4,558,135,430 units of POSACONAZOLE DR 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on August 17, 2022, with a ceiling value of $5,820.00. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 18, 2022. The contract is not designated as a Set-Aside. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) with an expiration date of June 11, 2025. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 8/17/22 |